UROKINASE-TYPE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS AS GROWTH-FACTORS OF HUMAN FIBROBLASTS

被引:80
作者
DEPETRO, G [1 ]
COPETA, A [1 ]
BARLATI, S [1 ]
机构
[1] UNIV BRESCIA, DEPT BIOMED SCI & BIOTECHNOL, DIV BIOL & GENET, I-25123 BRESCIA, ITALY
关键词
D O I
10.1006/excr.1994.1200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study we have verified the mitogenic effect of urokinase-type (u-PA) and tissue-type plasminogen activators (t-PA) on human normal fibroblasts. We report that both PAs can induce DNA replication and cell division in serum-deprived cultured human skin fibroblasts. The activity of u-PA and t-PA is, respectively, three- and twofold more potent than that exerted by epidermal growth factor (EGF) with an activity slightly lower (50-60%) than that induced by basic fibroblast growth factor (bFGF). The u-PA and t-PA, but not plasmin, induced DNA synthesis, which could be neutralized by anti-u-PA and anti-t-PA antibodies, respectively, but was insensitive to aprotinin treatment. The addition of anti-u-PA-receptor (u-PAR) monoclonal antibodies to the assays selectively suppressed the mitogenic effect exerted by u-PA, but not that of t-PA, and the amino-terminal fragment of u-PA, containing the EGF-like domain and the kringle module, did not elicit any mitogenic activity. Anti-bFGF antibodies completely suppressed the mitogenic activity of bFGF, but did not have any effect on that of u-PA and t-PA; the activity of both PAs was inhibited by anti-fibronectin IgG concentrations ineffective on bFGF. These results indicate that PAs may be considered growth factors of human fibroblasts. (C) 1994 Academic Press, Inc.
引用
收藏
页码:286 / 294
页数:9
相关论文
共 26 条
  • [1] ANICHINI E, 1994, IN PRESS EXP CELL RE
  • [2] BARLATI S, 1988, CANCER J, V2, P95
  • [3] PLASMINOGEN ACTIVATORS IN DEVELOPING PERIPHERAL NERVOUS-SYSTEM, CELLULAR-ORIGIN AND MITOGENIC EFFECT
    BARON-VAN EVERCOOREN, A
    LEPRINCE, P
    ROGISTER, B
    LEFEBVRE, PP
    DELREE, P
    SELAK, I
    MOONEN, G
    [J]. DEVELOPMENTAL BRAIN RESEARCH, 1987, 36 (01): : 101 - 108
  • [4] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS
    BLASI, F
    VASSALLI, JD
    DANO, K
    [J]. JOURNAL OF CELL BIOLOGY, 1987, 104 (04) : 801 - 804
  • [5] STABILIZATION OF RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH-FACTOR BY CHEMICAL MODIFICATIONS OF CYSTEINE RESIDUES
    CACCIA, P
    NITTI, G
    CLETINI, O
    PUCCI, P
    RUOPPOLO, M
    BERTOLERO, F
    VALSASINA, B
    ROLETTO, F
    CRISTIANI, C
    CAUET, G
    SARMIENTOS, P
    MALORNI, A
    MARINO, G
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02): : 649 - 655
  • [6] TISSUE-TYPE PLASMINOGEN-ACTIVATOR, BUT NOT UROKINASE, EXERTS TRANSFORMATION-ENHANCING ACTIVITY
    DEPETRO, G
    VARTIO, T
    SALONEN, EM
    VAHERI, A
    BARLATI, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) : 563 - 567
  • [7] DEPETRO G, 1989, CANCER J, V2, P231
  • [8] PLASMINOGEN - PURIFICATION FROM HUMAN PLASMA BY AFFINITY CHROMATOGRAPHY
    DEUTSCH, DG
    MERTZ, ET
    [J]. SCIENCE, 1970, 170 (3962) : 1095 - +
  • [9] THE MR 17500 REGION OF THE A-CHAIN OF UROKINASE IS REQUIRED FOR INTERACTION WITH A SPECIFIC RECEPTOR IN A431 CELLS
    FIBBI, G
    DINI, G
    PASQUALI, F
    PUCCI, M
    DELROSSO, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 885 (03) : 301 - 308
  • [10] 2ND-GENERATION PLASMINOGEN ACTIVATORS
    HARRIS, TJR
    [J]. PROTEIN ENGINEERING, 1987, 1 (06): : 449 - 458